Formulation, release characteristics, and bioavailability study of gastroretentive floating matrix tablet and floating raft system of Mebeverine HCl

MA El Nabarawi, MH Teaima… - Drug design …, 2017 - Taylor & Francis
To prolong the residence time of dosage forms within the gastrointestinal tract until all drug
is released at the desired rate is one of the real challenges for oral controlled-release drug …
被引用次数：55 相关文章

Formulation, release characteristics, and bioavailability study of gastroretentive floating matrix tablet and floating raft system of Mebeverine HCl

MA El Nabarawi, MH Teaima… - Drug Design …, 2017 - search.proquest.com
To prolong the residence time of dosage forms within the gastrointestinal tract until all drug
is released at the desired rate is one of the real challenges for oral controlled-release drug …

Formulation, release characteristics, and bioavailability study of gastroretentive floating matrix tablet and floating raft system of Mebeverine HCl.

MA El Nabarawi, MH Teaima, AEM RA… - Drug Design …, 2017 - europepmc.org
To prolong the residence time of dosage forms within the gastrointestinal tract until all drug
is released at the desired rate is one of the real challenges for oral controlled-release drug …

Formulation, release characteristics, and bioavailability study of gastroretentive floating matrix tablet and floating raft system of Mebeverine HCl

MA El Nabarawi, MH Teaima… - Drug design …, 2017 - pubmed.ncbi.nlm.nih.gov
To prolong the residence time of dosage forms within the gastrointestinal tract until all drug
is released at the desired rate is one of the real challenges for oral controlled-release drug …

Formulation, release characteristics, and bioavailability study of gastroretentive floating matrix tablet and floating raft system of Mebeverine HCI

MA El Nabarawi, MH Teaima… - Drug Design …, 2017 - go.gale.com
To prolong the residence time of dosage forms within the gastrointestinal tract until all drug
is released at the desired rate is one of the real challenges for oral controlled-release drug …

Formulation, release characteristics, and bioavailability study of gastroretentive floating matrix tablet and floating raft system of Mebeverine HCl

MA El Nabarawi, MH Teaima… - Drug Design …, 2017 - dovepress.com
To prolong the residence time of dosage forms within the gastrointestinal tract until all drug
is released at the desired rate is one of the real challenges for oral controlled-release drug …
[HTML] nih.gov

[HTML][HTML] Formulation, release characteristics, and bioavailability study of gastroretentive floating matrix tablet and floating raft system of Mebeverine HCl

MA El Nabarawi, MH Teaima… - Drug Design …, 2017 - ncbi.nlm.nih.gov
To prolong the residence time of dosage forms within the gastrointestinal tract until all drug
is released at the desired rate is one of the real challenges for oral controlled-release drug …

Formulation, release characteristics, and bioavailability study of gastroretentive floating matrix tablet and floating raft system of Mebeverine HCl.

MA El Nabarawi, MH Teaima, AEM RA… - Drug Design …, 2017 - europepmc.org
To prolong the residence time of dosage forms within the gastrointestinal tract until all drug
is released at the desired rate is one of the real challenges for oral controlled-release drug …